3
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Disappearance Rate of 133Xenon, 4-Iodoantipyrine- 131I and 131I-from Human Skeletal Muscles and Adipose Tissue

Pages 120-128 | Received 12 Sep 1966, Published online: 08 Jul 2009
 

Abstract

Lindbjerg, I. F. Disappearance Rate of 133Xenon, 4-Iodo-antipyrine-131I and 131I-from Human Skeletal Muscles and Adipose Tissue. Scand. J. clin. Lab. Invest. 19, 120-128, 1967. A comparison of the disappearance of 133Xe and 131I-tagged 4-iodo-antipyrine (131I-AP), simultaneously injected in human leg muscles, was performed at rest and during hyperaemia, produced by maximal muscular exercise during ischaemia.

At rest the ratio between 133Xe and 131I-antipyrine removal rates in 16 legs of subjects<70 years of age averaged 0.78 (S. D. 0.10); in 8 legs of subjects ⩾ 70 years it was significantly lower, averaging 0.59 (S. D. 0.17); p<0.01. In 10 legs of subjects of all ages, the ratio was 0.68 (S. D. 0.12) at rest and 0.72 (S. D. 0.12) during hyperaemia. This difference is not significant.

In contrast, the ratio between removal rates of 133Xe and 131I-increased from 0.94 at rest to 1.98 during hyperaemia, indicating a relatively slower removal of 131I-at higher blood-flows.

In subcutaneous adipose tissue the 133Xe/131I-AP-removal ratio was 0.102 (S. D. 0.050).

The findings are compatible with maintenance of diffusion equilibrium between tissue and blood in respect to the lipid-soluble indicators 133Xe and 131I-Ap, while the removal of free 131I-seems to be impeded at high blood-flows.

Variation of the Xe/I-AP removal ratio in muscle is probably mainly caused by varying fat content.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.